Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis

Amyotrophic lateral sclerosis (ALS) phenotypes such as limb ALS, bulbar ALS, primary lateral sclerosis and primary muscular atrophy are highly heterogeneous and exist on a continuum. These are largely determined by the neuroanatomy of the underlying pathological changes, which can be clinically imputed. Deconstructing these early in disease, before temporal-spatial summation induces complexity, shows that ALS begins focally at a seemingly random location and progresses contiguously. This suggests that focality and anatomic propagation of pathology are significant parts of pathogenesis-disease propagates over space as well as progresses over time. Focality and neuroanatomic propagation can explain how dominant genetic traits manifest with heterogeneous phenotypes, since the anatomic site of outbreak is a prime determinant of phenotype. Focality and neuroanatomic propagation can also explain why frontotemporal dementia (FTD), a neurodegeneration closely related to ALS, has heterogeneous phenotypes, since here too the anatomic site of the outbreak is a prime determinant of phenotype. There are two distinct types of neuroanatomic propagation: contiguous propagation, which occurs side-to-side regionally through the extracellular matrix independent of synaptic connection; and network propagation, which occurs end-to-end dependent on synaptic connections and axonal transmission in connected neuronal networks. The molecular basis of neuroanatomic propagation is unknown, although prion-like misfolding and templating of pathogenic proteins is a compelling unifying hypothesis.

[1]  B. Miller,et al.  Are amyotrophic lateral sclerosis patients cognitively normal? , 2003, Neurology.

[2]  A. L. La Spada,et al.  ALS motor phenotype heterogeneity, focality, and spread , 2009, Neurology.

[3]  C. van Broeckhoven,et al.  The genetics and neuropathology of frontotemporal lobar degeneration , 2012, Acta Neuropathologica.

[4]  S. Petri,et al.  Onset and spreading patterns of upper and lower motor neuron symptoms in amyotrophic lateral sclerosis , 2011, Muscle & nerve.

[5]  Takayoshi Kobayashi,et al.  Spreading of amyotrophic lateral sclerosis lesions—multifocal hits and local propagation? , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[6]  P. Andres,et al.  The natural history of motoneuron loss in amyotrophic lateral sclerosis , 1988, Neurology.

[7]  J. Burgunder,et al.  Recent progress in the genetics of motor neuron disease. , 2014, European journal of medical genetics.

[8]  D. Gutmann,et al.  Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis , 2008, Nature Neuroscience.

[9]  Tapan P. Patel,et al.  Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death , 2011, Neuron.

[10]  D. Holtzman,et al.  Trans-cellular Propagation of Tau Aggregation by Fibrillar Species* , 2012, The Journal of Biological Chemistry.

[11]  J. Trojanowski,et al.  Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy , 2011, Acta Neuropathologica.

[12]  M. Turner,et al.  Pattern of spread and prognosis in lower limb-onset ALS , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[13]  D. Cleveland,et al.  Rethinking ALS: The FUS about TDP-43 , 2009, Cell.

[14]  Christian Münch,et al.  Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells , 2011, Proceedings of the National Academy of Sciences.

[15]  Lawrence Rajendran,et al.  The Transcellular Spread of Cytosolic Amyloids, Prions, and Prionoids , 2009, Neuron.

[16]  S. Sakoda,et al.  Nuclear TAR DNA Binding Protein 43 Expression in Spinal Cord Neurons Correlates With the Clinical Course in Amyotrophic Lateral Sclerosis , 2009, Journal of neuropathology and experimental neurology.

[17]  A. Spada,et al.  Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy , 2014, Neuron.

[18]  P. Andres,et al.  Quantitative assessment of neuromuscular deficit in ALS. , 1987, Neurologic clinics.

[19]  L. Zinman,et al.  Evidence That TDP-43 is Not the Major Ubiquitinated Target Within the Pathological Inclusions of Amyotrophic Lateral Sclerosis , 2007, Journal of neuropathology and experimental neurology.

[20]  D. Cleveland,et al.  Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis , 2013, Neuron.

[21]  Jacob I. Ayers,et al.  Intramuscular injection of α-synuclein induces CNS α-synuclein pathology and a rapid-onset motor phenotype in transgenic mice , 2014, Proceedings of the National Academy of Sciences.

[22]  S. M. Chou,et al.  Issues & Opinions: Amyotrophic lateral sclerosis: Lower motor neuron disease spreading to upper motor neurons , 1993, Muscle & nerve.

[23]  R. Sica,et al.  Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis , 2012, European journal of neurology.

[24]  John L. Robinson,et al.  TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord , 2014, Acta Neuropathologica.

[25]  W. Seeley,et al.  Selective functional, regional, and neuronal vulnerability in frontotemporal dementia , 2008, Current opinion in neurology.

[26]  J A Kiernan,et al.  Frontal lobe atrophy in motor neuron diseases. , 1994, Brain : a journal of neurology.

[27]  P. Weydt,et al.  Skeletal muscle in amyotrophic lateral sclerosis: emerging concepts and therapeutic implications. , 2005, Physical medicine and rehabilitation clinics of North America.

[28]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[29]  H. Braak,et al.  Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord , 2010, Acta Neuropathologica.

[30]  D. Mann,et al.  Prion-like properties of pathological TDP-43 aggregates from diseased brains. , 2013, Cell reports.

[31]  Yuxin Fan,et al.  Implications of ALS focality , 2007, Neurology.

[32]  Murray Grossman,et al.  Stages of pTDP‐43 pathology in amyotrophic lateral sclerosis , 2013, Annals of neurology.

[33]  Hitoshi Takahashi,et al.  Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia , 2008, Acta Neuropathologica.

[34]  J. Ravits,et al.  Focality of upper and lower motor neuron degeneration at the clinical onset of ALS , 2007, Neurology.

[35]  A. Chiò,et al.  Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[36]  T. Chow What Are the Different Initial Presentations of Frontotemporal Dementia? , 2011, Journal of Molecular Neuroscience.

[37]  Minh N. H. Nguyen,et al.  Wild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice , 2003, Science.

[38]  G. Forster,et al.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS , 2003, Neurology.

[39]  Ravi S. Menon,et al.  A prospective study of cognitive impairment in ALS , 1999, Neurology.

[40]  T. Yokota,et al.  Can regional spreading of amyotrophic lateral sclerosis motor symptoms be explained by prion-like propagation? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[41]  H. Akiyama,et al.  Clinicopathological characteristics of FTLD-TDP showing corticospinal tract degeneration but lacking lower motor neuron loss , 2010, Journal of the Neurological Sciences.

[42]  A. Hill,et al.  Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.

[43]  Adriano Chiò,et al.  State of play in amyotrophic lateral sclerosis genetics , 2013, Nature Neuroscience.

[44]  D. Cleveland,et al.  The Seeds of Neurodegeneration: Prion-like Spreading in ALS , 2011, Cell.

[45]  J. Kumagai,et al.  Non-human primate model of amyotrophic lateral sclerosis with cytoplasmic mislocalization of TDP-43 , 2012, Brain : a journal of neurology.

[46]  B. Miller,et al.  Neurodegenerative Diseases Target Large-Scale Human Brain Networks , 2009, Neuron.

[47]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[48]  N. Nukina,et al.  A Seeding Reaction Recapitulates Intracellular Formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding Protein-43 Inclusions*♦ , 2011, The Journal of Biological Chemistry.

[49]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[50]  David Heckerman,et al.  A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.

[51]  B. Pant,et al.  Amyotrophic lateral sclerosis (ALS): A phylogenetic disease of the corticomotoneuron? , 1992, Muscle & nerve.

[52]  Bruce L. Miller,et al.  Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.

[53]  A. Kakita,et al.  Primary lateral sclerosis: Upper‐motor‐predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration – immunohistochemical and biochemical analyses of TDP‐43 , 2012, Neuropathology : official journal of the Japanese Society of Neuropathology.

[54]  Xiao-dong Pan,et al.  Clinic, neuropathology and molecular genetics of frontotemporal dementia: a mini-review , 2013, Translational Neurodegeneration.

[55]  E. Buratti,et al.  Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[56]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[57]  B. Brooks The Role of Axonal Transport in Neurodegenerative Disease Spread: A Meta-Analysis of Experimental and Clinical Poliomyelitis Compares with Amyotrophic Lateral Sclerosis , 1991, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[58]  Daniel Stahl,et al.  Latent Cluster Analysis of ALS Phenotypes Identifies Prognostically Differing Groups , 2009, PloS one.

[59]  R. Lemon Descending pathways in motor control. , 2008, Annual review of neuroscience.

[60]  John Q. Trojanowski,et al.  Amyotrophic lateral sclerosis—a model of corticofugal axonal spread , 2013, Nature Reviews Neurology.

[61]  T. Hanafusa,et al.  Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.